📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Broad evidence of xylazine in the UK illicit drug market beyond heroin supplies: Triangulating from toxicology, drug-testing and law enforcement. (2024)

First Author: Copeland CS

Attributed to: The ReSPect Study - Reducing stigma towards people with issues related to drug use funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/add.16466

PubMed Identifier: 38593992

Publication URI: http://europepmc.org/abstract/MED/38593992

Type: Journal Article/Review

Volume: 119

Parent Publication: Addiction (Abingdon, England)

Issue: 7

ISSN: 0965-2140